Incyte (INCY): Tumor Removal Drives Estimate Cut - UBS

February 12, 2016 8:57 AM

UBS analyst, Matthew Roden, looked through a good quarter for Incyte (NASDAQ: INCY) to the importance of pipeline growth ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found